DOW JONES27,081.36-879.44 -3.15%
S&P 5003,128.21-97.68 -3.03%
NASDAQ8,965.61-255.67 -2.77%

UBS Maintains Buy on Merck & Co, Lowers Price Target to $96

UBS maintains Merck & Co (NYSE:MRK) with a Buy and lowers the price target from $99 to $96.

Benzinga · 02/06/2020 12:48

UBS maintains Merck & Co (NYSE:MRK) with a Buy and lowers the price target from $99 to $96.